You are on page 1of 4

BUSINESS EDITORS' PICK

Researchers Warn Some Covid-19 Vaccines Could


Increase Risk Of HIV Infection
Robert Hart
Forbes Staff Follow
I cover breaking news.

Oct 20, 2020, 01:43pm EDT 0

Listen to article 3 minutes New!

Click on the conversation bubble to


join the conversation

Got it!
Updated Apr 14, 2022, 02:05pm EDT

GETTY

TOPLINE Some of the Covid-19 vaccines currently in development could increase


the risk of acquiring HIV, warned a group of researchers in the The Lancet medical
journal Monday, potentially leading to an increase in infections as vaccines are
rolled out to vulnerable populations around the world. 

More From Forbes

KEY FACTS

• The researchers warn of a “cautionary tale” from efforts to create an HIV


vaccine over a decade ago, where a promising vaccine candidate actually
increased the risk of some men catching the virus.

• The vaccine made use of a modified virus — called adenovirus 5 (Ad5) — as a


vector to transport some of HIV’s genetic material into the body. 

• Exactly how the vaccine increased the risks of HIV transmission is unknown, but
a conference convened by the National Institutes of Health recommended
against further use of Ad5 as a vector in HIV vaccines (Dr. Anthony Fauci was
lead author of the paper outlining this position.)  

• Ad5 is used as a vector in some Covid-19 vaccines —  Science identifies four such
candidates that are currently undergoing clinical trials in various countries
around the world, including the U.S., with two in large scale phase 3 trials
ongoing in Russia and Pakistan. 
• The researchers stressed the need to understand the role Ad5 might play in
increasing the risks of HIV in vulnerable populations before developing and
deploying vaccines using the vector, adding that informed consent documents
should reflect the “considerable literature” on the risk of HIV acquisition with
Ad5 vectors. 

KEY BACKGROUND

Lots of vaccines make use of modified viruses to transport material into the human
body. Many make use of a modified adenovirus to do this, a virus which is usually
harmless except the ability to cause the common cold. Some of the leading
candidates for a Covid-19 vaccine, including those from Johnson & Johnson and 
AstraZeneca, use adenoviruses as vectors. There is no evidence that those vectors
increase the risk of HIV infection.

CRUCIAL QUOTE

The authors said they went public because Ad5 vaccines for Covid-19 might soon
be tested in populations with high HIV prevalence. Lawrence Corey, one of the
authors who now co-leads the Covid-19 prevention network in the U.S. that is
testing vaccines on behalf of the NIH, told Science that if he were in a sub-Saharan
African country, where there’s a high prevalence of HIV, “I don’t see why I would
pick an Ad5 vector (vaccine) when there are many other alternative choices.”  

FURTHER READING

Could certain COVID-19 vaccines leave people more vulnerable to the AIDS virus?
(Science)

Use of adenovirus type-5 vectored vaccines: a cautionary tale (The Lancet)

Full coverage and live updates on the Coronavirus

Follow me on Twitter or LinkedIn. Send me a secure tip.

Robert Hart Follow

I am a senior reporter for the Forbes breaking news team, covering health and... Read More

Editorial Standards Corrections Reprints & Permissions

ADVERTISEMENT
© 2022 Forbes Media LLC. All Rights Reserved.
AdChoices Privacy Statement Do Not Sell My Personal Information Terms and Conditions Contact Us
Report a Security Issue Jobs At Forbes Reprints & Permissions Forbes Press Room Advertise

You might also like